Antibiotic‐treated infections in intensive care patients in the UK

Summary The purpose of this audit was to study reasons for starting antibiotic therapy, duration of antibiotic treatment, reasons for changing antibiotics and the agreement between clinical suspicion and microbiological results in intensive care practice. We conducted a multicentre observational aud...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Anaesthesia 2004-09, Vol.59 (9), p.885-890
Hauptverfasser: Cuthbertson, B. H., Thompson, M., Sherry, A., Wright, M. M., Bellingan, G. J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 890
container_issue 9
container_start_page 885
container_title Anaesthesia
container_volume 59
creator Cuthbertson, B. H.
Thompson, M.
Sherry, A.
Wright, M. M.
Bellingan, G. J.
description Summary The purpose of this audit was to study reasons for starting antibiotic therapy, duration of antibiotic treatment, reasons for changing antibiotics and the agreement between clinical suspicion and microbiological results in intensive care practice. We conducted a multicentre observational audit of 316 patients. Data on demographic details, site, treatment and nature of infection were collected. The median duration of antibiotic therapy was 7 days. Infections were community‐acquired in 160 patients (55%). Antibiotics were started on clinical suspicion of infection in 237 patients (75%). Pulmonary infections were the most common, representing 52% of all proven infections. Gram‐negative organisms were the most common cause of proven infections (n = 90 (50%)). The antibiotic spectrum was narrowed in light of microbiology results in 78 patients (43%) and changed due to antibiotic resistance in 38 patients (21%). We conclude that the mean duration of treatment contrasts with existing published guidelines, highlighting the need for further studies on duration and efficacy of treatment in intensive care.
doi_str_mv 10.1111/j.1365-2044.2004.03742.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66783092</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20196586</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4772-748dea89d9f7ad6a4c394d689128d2bf630aef592067082d387d63b94de59c053</originalsourceid><addsrcrecordid>eNqNkM1u1DAQgC0EokvhFapc2lvC-Df2pdKqlB9RwYWeLa89Ub3KJtvY258bj8Az8iQ43RU9wsjSjDTfjEcfIRWFhpZ4v24oV7JmIETDAEQDvBWseXhBFn8bL8kCAHjNBJgj8ialNQBlmurX5IhKToFLtiAflkOOqzjm6H___JUndBlDFYcOfY7jkEpZXsYhxTusvJuw2roccchPrXyD1fXXt-RV5_qE7w75mFx_vPxx8bm--v7py8XyqvaibVndCh3QaRNM17qgnPDciKC0KWcFtuoUB4edNAxUC5oFrtug-KowKI0HyY_J2X7vdhpvd5iy3cTkse_dgOMuWaVazcGwf4IMqFFSqwLqPeinMaUJO7ud4sZNj5aCnVXbtZ2N2tmonVXbJ9X2oYyeHP7YrTYYngcPbgtwegBc8q7vJjf4mJ45BUxISQt3vufuY4-P_32AXX5bXs4l_wNgOZlq</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20196586</pqid></control><display><type>article</type><title>Antibiotic‐treated infections in intensive care patients in the UK</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Wiley Online Library Free Content</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Cuthbertson, B. H. ; Thompson, M. ; Sherry, A. ; Wright, M. M. ; Bellingan, G. J.</creator><creatorcontrib>Cuthbertson, B. H. ; Thompson, M. ; Sherry, A. ; Wright, M. M. ; Bellingan, G. J. ; Intensive Care Society ; the Intensive Care Society</creatorcontrib><description>Summary The purpose of this audit was to study reasons for starting antibiotic therapy, duration of antibiotic treatment, reasons for changing antibiotics and the agreement between clinical suspicion and microbiological results in intensive care practice. We conducted a multicentre observational audit of 316 patients. Data on demographic details, site, treatment and nature of infection were collected. The median duration of antibiotic therapy was 7 days. Infections were community‐acquired in 160 patients (55%). Antibiotics were started on clinical suspicion of infection in 237 patients (75%). Pulmonary infections were the most common, representing 52% of all proven infections. Gram‐negative organisms were the most common cause of proven infections (n = 90 (50%)). The antibiotic spectrum was narrowed in light of microbiology results in 78 patients (43%) and changed due to antibiotic resistance in 38 patients (21%). We conclude that the mean duration of treatment contrasts with existing published guidelines, highlighting the need for further studies on duration and efficacy of treatment in intensive care.</description><identifier>ISSN: 0003-2409</identifier><identifier>EISSN: 1365-2044</identifier><identifier>DOI: 10.1111/j.1365-2044.2004.03742.x</identifier><identifier>PMID: 15310352</identifier><identifier>CODEN: ANASAB</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Ltd</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Anesthesia ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Anti-Bacterial Agents - administration &amp; dosage ; Antibiotics ; Bacterial Infections - drug therapy ; Biological and medical sciences ; Community-Acquired Infections - drug therapy ; Critical Care - methods ; Cross Infection - drug therapy ; Drug Administration Schedule ; Female ; Guideline Adherence ; Humans ; Infection ; Intensive care ; Male ; Medical Audit ; Medical sciences ; Middle Aged ; Practice Guidelines as Topic ; Practice Patterns, Physicians' - statistics &amp; numerical data ; United Kingdom</subject><ispartof>Anaesthesia, 2004-09, Vol.59 (9), p.885-890</ispartof><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4772-748dea89d9f7ad6a4c394d689128d2bf630aef592067082d387d63b94de59c053</citedby><cites>FETCH-LOGICAL-c4772-748dea89d9f7ad6a4c394d689128d2bf630aef592067082d387d63b94de59c053</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2044.2004.03742.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2044.2004.03742.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,1427,27901,27902,45550,45551,46384,46808</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16024551$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15310352$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cuthbertson, B. H.</creatorcontrib><creatorcontrib>Thompson, M.</creatorcontrib><creatorcontrib>Sherry, A.</creatorcontrib><creatorcontrib>Wright, M. M.</creatorcontrib><creatorcontrib>Bellingan, G. J.</creatorcontrib><creatorcontrib>Intensive Care Society</creatorcontrib><creatorcontrib>the Intensive Care Society</creatorcontrib><title>Antibiotic‐treated infections in intensive care patients in the UK</title><title>Anaesthesia</title><addtitle>Anaesthesia</addtitle><description>Summary The purpose of this audit was to study reasons for starting antibiotic therapy, duration of antibiotic treatment, reasons for changing antibiotics and the agreement between clinical suspicion and microbiological results in intensive care practice. We conducted a multicentre observational audit of 316 patients. Data on demographic details, site, treatment and nature of infection were collected. The median duration of antibiotic therapy was 7 days. Infections were community‐acquired in 160 patients (55%). Antibiotics were started on clinical suspicion of infection in 237 patients (75%). Pulmonary infections were the most common, representing 52% of all proven infections. Gram‐negative organisms were the most common cause of proven infections (n = 90 (50%)). The antibiotic spectrum was narrowed in light of microbiology results in 78 patients (43%) and changed due to antibiotic resistance in 38 patients (21%). We conclude that the mean duration of treatment contrasts with existing published guidelines, highlighting the need for further studies on duration and efficacy of treatment in intensive care.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anesthesia</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Anti-Bacterial Agents - administration &amp; dosage</subject><subject>Antibiotics</subject><subject>Bacterial Infections - drug therapy</subject><subject>Biological and medical sciences</subject><subject>Community-Acquired Infections - drug therapy</subject><subject>Critical Care - methods</subject><subject>Cross Infection - drug therapy</subject><subject>Drug Administration Schedule</subject><subject>Female</subject><subject>Guideline Adherence</subject><subject>Humans</subject><subject>Infection</subject><subject>Intensive care</subject><subject>Male</subject><subject>Medical Audit</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Practice Guidelines as Topic</subject><subject>Practice Patterns, Physicians' - statistics &amp; numerical data</subject><subject>United Kingdom</subject><issn>0003-2409</issn><issn>1365-2044</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkM1u1DAQgC0EokvhFapc2lvC-Df2pdKqlB9RwYWeLa89Ub3KJtvY258bj8Az8iQ43RU9wsjSjDTfjEcfIRWFhpZ4v24oV7JmIETDAEQDvBWseXhBFn8bL8kCAHjNBJgj8ialNQBlmurX5IhKToFLtiAflkOOqzjm6H___JUndBlDFYcOfY7jkEpZXsYhxTusvJuw2roccchPrXyD1fXXt-RV5_qE7w75mFx_vPxx8bm--v7py8XyqvaibVndCh3QaRNM17qgnPDciKC0KWcFtuoUB4edNAxUC5oFrtug-KowKI0HyY_J2X7vdhpvd5iy3cTkse_dgOMuWaVazcGwf4IMqFFSqwLqPeinMaUJO7ud4sZNj5aCnVXbtZ2N2tmonVXbJ9X2oYyeHP7YrTYYngcPbgtwegBc8q7vJjf4mJ45BUxISQt3vufuY4-P_32AXX5bXs4l_wNgOZlq</recordid><startdate>200409</startdate><enddate>200409</enddate><creator>Cuthbertson, B. H.</creator><creator>Thompson, M.</creator><creator>Sherry, A.</creator><creator>Wright, M. M.</creator><creator>Bellingan, G. J.</creator><general>Blackwell Science Ltd</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>200409</creationdate><title>Antibiotic‐treated infections in intensive care patients in the UK</title><author>Cuthbertson, B. H. ; Thompson, M. ; Sherry, A. ; Wright, M. M. ; Bellingan, G. J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4772-748dea89d9f7ad6a4c394d689128d2bf630aef592067082d387d63b94de59c053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anesthesia</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Anti-Bacterial Agents - administration &amp; dosage</topic><topic>Antibiotics</topic><topic>Bacterial Infections - drug therapy</topic><topic>Biological and medical sciences</topic><topic>Community-Acquired Infections - drug therapy</topic><topic>Critical Care - methods</topic><topic>Cross Infection - drug therapy</topic><topic>Drug Administration Schedule</topic><topic>Female</topic><topic>Guideline Adherence</topic><topic>Humans</topic><topic>Infection</topic><topic>Intensive care</topic><topic>Male</topic><topic>Medical Audit</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Practice Guidelines as Topic</topic><topic>Practice Patterns, Physicians' - statistics &amp; numerical data</topic><topic>United Kingdom</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cuthbertson, B. H.</creatorcontrib><creatorcontrib>Thompson, M.</creatorcontrib><creatorcontrib>Sherry, A.</creatorcontrib><creatorcontrib>Wright, M. M.</creatorcontrib><creatorcontrib>Bellingan, G. J.</creatorcontrib><creatorcontrib>Intensive Care Society</creatorcontrib><creatorcontrib>the Intensive Care Society</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Anaesthesia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cuthbertson, B. H.</au><au>Thompson, M.</au><au>Sherry, A.</au><au>Wright, M. M.</au><au>Bellingan, G. J.</au><aucorp>Intensive Care Society</aucorp><aucorp>the Intensive Care Society</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antibiotic‐treated infections in intensive care patients in the UK</atitle><jtitle>Anaesthesia</jtitle><addtitle>Anaesthesia</addtitle><date>2004-09</date><risdate>2004</risdate><volume>59</volume><issue>9</issue><spage>885</spage><epage>890</epage><pages>885-890</pages><issn>0003-2409</issn><eissn>1365-2044</eissn><coden>ANASAB</coden><abstract>Summary The purpose of this audit was to study reasons for starting antibiotic therapy, duration of antibiotic treatment, reasons for changing antibiotics and the agreement between clinical suspicion and microbiological results in intensive care practice. We conducted a multicentre observational audit of 316 patients. Data on demographic details, site, treatment and nature of infection were collected. The median duration of antibiotic therapy was 7 days. Infections were community‐acquired in 160 patients (55%). Antibiotics were started on clinical suspicion of infection in 237 patients (75%). Pulmonary infections were the most common, representing 52% of all proven infections. Gram‐negative organisms were the most common cause of proven infections (n = 90 (50%)). The antibiotic spectrum was narrowed in light of microbiology results in 78 patients (43%) and changed due to antibiotic resistance in 38 patients (21%). We conclude that the mean duration of treatment contrasts with existing published guidelines, highlighting the need for further studies on duration and efficacy of treatment in intensive care.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Ltd</pub><pmid>15310352</pmid><doi>10.1111/j.1365-2044.2004.03742.x</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0003-2409
ispartof Anaesthesia, 2004-09, Vol.59 (9), p.885-890
issn 0003-2409
1365-2044
language eng
recordid cdi_proquest_miscellaneous_66783092
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Wiley Online Library Free Content; EZB-FREE-00999 freely available EZB journals
subjects Adolescent
Adult
Aged
Aged, 80 and over
Anesthesia
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Anti-Bacterial Agents - administration & dosage
Antibiotics
Bacterial Infections - drug therapy
Biological and medical sciences
Community-Acquired Infections - drug therapy
Critical Care - methods
Cross Infection - drug therapy
Drug Administration Schedule
Female
Guideline Adherence
Humans
Infection
Intensive care
Male
Medical Audit
Medical sciences
Middle Aged
Practice Guidelines as Topic
Practice Patterns, Physicians' - statistics & numerical data
United Kingdom
title Antibiotic‐treated infections in intensive care patients in the UK
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T06%3A00%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antibiotic%E2%80%90treated%20infections%20in%20intensive%20care%20patients%20in%20the%20UK&rft.jtitle=Anaesthesia&rft.au=Cuthbertson,%20B.%20H.&rft.aucorp=Intensive%20Care%20Society&rft.date=2004-09&rft.volume=59&rft.issue=9&rft.spage=885&rft.epage=890&rft.pages=885-890&rft.issn=0003-2409&rft.eissn=1365-2044&rft.coden=ANASAB&rft_id=info:doi/10.1111/j.1365-2044.2004.03742.x&rft_dat=%3Cproquest_cross%3E20196586%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20196586&rft_id=info:pmid/15310352&rfr_iscdi=true